No. | Content | Page |
| Executive summary | 1 |
I | Development of policy environment for paclitaxel injection in China | 3 |
I-1 | Regulation in GMP about paclitaxel injection | 4 |
I-2 | Regulation about paclitaxel injection in CP 2000 | 6 |
II | Production of paclitaxel injection in China | 7 |
II-1 | Production data from 2005 to 2009 | 7 |
II-2 | Regional distribution of paclitaxel injection production | 7 |
II-3 | Summary of paclitaxel injection manufacturers in China, 2008&2009 | 10 |
II-4 | Competition analysis of paclitaxel injection producers | 12 |
III | Production of paclitaxel APIs in China | 13 |
IV | China’s paclitaxel injection distribution model | 17 |
IV-1 | Pharmaceutical distribution business in China | 17 |
IV-1.1 | Development history of pharmaceutical distribution business in China | 17 |
IV-1.2 | China’s major regional market share of pharmaceutical distribution business | 19 |
IV-1.3 | Sales value and concentration of pharmaceutical distribution business in China | 20 |
IV-2 | Introduction to distribution of paclitaxel injection with Chinese characteristic | 21 |
V | China’s medicine bidding and purchasing platform | 23 |
V-1 | Background of medicine bidding and purchasing platform | 23 |
V-2 | Flow chart of medicine bidding and purchasing platform | 23 |
V-3 | Top two pharmaceutical distribution companies | 24 |
VI | Consumption of paclitaxel injection in China | 27 |
VI-1 | Overview of anticancer drugs in China | 27 |
VI-1.1 | Consumption situation of natural anticancer drugs | 28 |
VI-2 | Consumption situation of paclitaxel injection | 28 |
VI-2.1 | Consumption in end-user sectors | 30 |
VI-2.1.1 | NSCLC | 30 |
VI-2.1.2 | Breast cancer | 31 |
VI-2.1.3 | Ovarian cancer | 32 |
VI-2.2 | Distribution of paclitaxel injection consumption in top five provinces | 33 |
VI-3 | Consumption potential analysis of paclitaxel injection in next 5 years | 34 |
VI-3.1 | Influencing factors for consumption | 34 |
VI-3.2 | Forecast consumption of paclitaxel injection in China, 2010-2015 | 35 |
VII | Import and export situation in 2009 | 38 |
VII-1 | Import and export situation for paclitaxel injection | 38 |
VII-2 | Export situation for paclitaxel APIs | 39 |
VIII | Resource of yew in China | 41 |
IX | Profile of major manufacturers of paclitaxel injection in China | 44 |
IX-1 | Sichuan Jiufeng Pharmaceutical Co., Ltd. | 44 |
... | | 0 |
IX-10 | Youcare Pharmaceutical Group Co., Ltd. | 50 |